In this file
Comparing alternatives to Calibrate is easier when you first identify what needs to change. If the structured curriculum is what attracted you to Calibrate, a medication bundle may not replace the same support. Compare scheduled coaching, clinical appointments, and the first term’s obligation as separate features.
The provider’s current comparison point is: The membership pays for a structured program while labs and medicine remain separate. The entries below offer different care and payment arrangements to examine against that point.
How to use this shortlist
CoreAge Rx is listed first under a commercial partnership. The first position is predetermined by that relationship, and links may earn compensation. It is not an independent finding that CoreAge has the safest medicine, the lowest total price, or the strongest patient outcomes.
Use Calibrate’s documented arrangement as the baseline, then test the alternatives against coaching structure and care commitments. We compare public care descriptions and payment terms. We have not purchased treatment, audited every professional license, or timed the support response. Use the linked source notes and obtain a current personal quote.
01. CoreAge Rx · sponsored first position
This is the paid featured reference for the question in this guide. Its placement does not establish that every feature discussed here is available through its program. Ask about the exact product and care access before assuming a match.
CoreAge Rx provides an online route to medical assessment and, where a clinician prescribes, pharmacy fulfillment. The service is our paid featured partner. That commercial relationship buys its prominent position here; it does not establish a better medicine, a better outcome, or suitability for any particular reader.
The sale offer shows starting equivalents of $99 for semaglutide and $149 for tirzepatide, without a separate membership charge. Its billing explanation uses a three-month example: $149 per month becomes a single $447 payment. A reader should obtain the duration and total for the selected prescription rather than assuming that the smaller figure is charged monthly.
A question to put to the provider: Can you send the full payment schedule and the name of my dispensing pharmacy before I accept the offer?
Read the CoreAge Rx provider file and cost explanation for the connected details.
02. WeightWatchers Med+ (Clinic)
The comparison point for WeightWatchers Med+ (Clinic): Med+ introductory pricing is tied to a longer medical membership.
WeightWatchers Med+ combines clinical access with nutrition and behavior-change tools. A standard WeightWatchers app plan and the medical program are distinct services, so overlapping subscriptions deserve attention.
The medical offer advertises $25 for month one, then $84 monthly on a six-month term or $74 on a twelve-month term. The medicine is billed separately. Confirm renewal and the entire remaining membership obligation.
A question to put to the provider: Does joining or leaving Med+ replace my other WeightWatchers subscription, and what drug cost is outside membership?
The WeightWatchers Med+ (Clinic) alternatives guide examines this arrangement in more detail. You can also consult the official provider page.
03. Shapely
The comparison point for Shapely: Scheduled provider contact and dietitian access need to be priced alongside the medicine.
Shapely describes monthly video visits, nutrition-professional access, and help with insurance and pharmacy coordination. Its self-pay and insured arrangements should be compared as separate care pathways.
The advertised self-pay membership begins at $49 for the first month and $99 thereafter. Medication is not included, and laboratory charges may apply. An insured visit does not by itself establish a covered weight-loss prescription.
A question to put to the provider: Which provider and dietitian appointments are included in my selected pathway, and what remains payable separately?
The Shapely alternatives guide examines this arrangement in more detail. You can also consult the official provider page.
04. Sesame Care
The comparison point for Sesame Care: The lowest care equivalent requires a longer commitment and excludes medication.
Success by Sesame describes recurring video appointments, clinician messaging, and an ongoing provider relationship. Confirm that the selected subscription includes the visit cadence you want.
The care offer starts at $59 per month on a twelve-month commitment, compared with a $99 month-to-month option. Medication is separate. Cancellation conditions distinguish the period before the initial appointment from the period afterward.
A question to put to the provider: What is the full care obligation after the first appointment, and what will the chosen pharmacy charge?
Use the official Sesame Care page to request the current plan and conditions.
05. Noom Med
The comparison point for Noom Med: A standard app subscription and Noom Med are distinct enrollment choices.
Noom Med combines medical access with Noom’s behavior-change tools. App membership alone does not establish access to the same clinical service, prescription, or pharmacy process. Readers should name the medical pathway before comparing its value.
The page describes direct GLP-1 access starting at $79 and an insurance-related route starting at $39 plus the drug’s out-of-pocket cost. These are different offers. Determine the duration, included medicine or care, and whether an existing app payment is replaced or remains active.
A question to put to the provider: Which Noom subscriptions will I be paying for after joining Med, and what happens to each when medical care ends?
Read the Noom Med provider file and cost explanation for the connected details.
06. PlushCare
The comparison point for PlushCare: Membership, appointments, tests, and medicine are separately identifiable costs.
PlushCare uses a primary-care video-visit model and describes prior-authorization help when appropriate. Insurance is accepted but not required, and the cost depends on the patient’s own plan.
Published figures include a $19.99 monthly membership after the introductory free month and a $129 uninsured initial appointment. Prescriptions and laboratory testing are additional; insured appointment costs depend on coverage.
A question to put to the provider: What will a follow-up appointment cost, and does my insurer cover the specific drug as well as the visit?
Use the official PlushCare page to request the current plan and conditions.
Your starting point: Calibrate
Calibrate describes a clinician video appointment, individual coaching by video, and a curriculum. Insurance navigation is part of the service, but an authorization decision remains with the insurer.
Membership is listed at $199 monthly with an initial three-month obligation of $597 paid in installments. Medication and laboratory testing are excluded. A low drug copay example is not the complete cost of that commitment.
What will I owe for the first three months if medication coverage is unavailable?
Make the decision concrete
Bring these three checks to the shortlist. If an answer describes another product, a different payment period, or a service you are not eligible for, the comparison is not finished.
- Distinguish a coaching appointment from a prescribing appointment when comparing visit frequency.
- Request the named product, total initial payment, and next renewal in the same written quote.
- Confirm how the receiving clinician reviews existing treatment and how questions are handled between orders.
Separate the product from the provider
FDA approval belongs to a particular drug product, not to a review site’s list or a telehealth brand. A compounded preparation has not received that approval. Ingredient similarity does not establish the same route, formulation, manufacturing controls, or evidence.
Ask the clinician why the exact prescription fits your medical needs. Then ask the pharmacy for the label and instructions appropriate to that product. Read what compounding and FDA approval mean if those terms are being used interchangeably in a promotion.
Before accepting another offer
Keep the current agreement, prescription label, and any pending order information together. A new enrollment does not automatically stop the previous company’s next charge or authorize a continuation prescription.
Use the questions-before-purchase checklist to record the answers in your own words. A useful next step is a clear conversation and a complete proposal, not a decision based on a rank alone.
Source notes
Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.
- CoreAge Rx: official treatment overview ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: current sale offer ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: plan billing explained ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: contact and professional-entity disclosures ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: purchasing process ↗Provider-published information · Checked September 22, 2026
- WeightWatchers Med+ (Clinic): official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- Shapely: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- Sesame Care: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- Noom Med - GLP-1 Medications for Weight Loss ↗Provider-published information · Checked September 22, 2026
- Terms and Conditions of Use ↗Provider-published information · Checked September 22, 2026
- PlushCare: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- Calibrate: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- FDA: concerns with unapproved GLP-1 drugs ↗Regulatory / public agency · Checked September 22, 2026
- FDA: risks of compounded drugs ↗Regulatory / public agency · Checked September 22, 2026